Philips North America vs TCI Co., Ltd BioCosme PABP BRANCH: FDA Enforcement Comparison

Philips North America has been the subject of 369 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for TCI Co., Ltd BioCosme PABP BRANCH.

Philips North America: 0 warning letters, 369 recalls, 0 approval records, 0 Form 483s.

TCI Co., Ltd BioCosme PABP BRANCH: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

TCI Co., Ltd BioCosme PABP BRANCH — Warning letters1

Philips North America — Recalls369

TCI Co., Ltd BioCosme PABP BRANCH — Recalls0

Philips North America — Approval records0

TCI Co., Ltd BioCosme PABP BRANCH — Approval records0

Philips North America — Form 483s0

TCI Co., Ltd BioCosme PABP BRANCH — Form 483s0

Timeline

Philips North America

Most recent FDA action: October 7, 2026

Full history →

TCI Co., Ltd BioCosme PABP BRANCH

Most recent FDA action: September 2, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs TCI Co., Ltd BioCosme PABP BRANCH: FDA Enforcement Comparison." Argus HQ, accessed October 13, 2026. https://argushq.ai/compare/philips-north-america-vs-tci-co-ltd-biocosme-pabp-branch

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗